UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): January 26, 2006
Cardinal Health, Inc.
(Exact Name of Registrant as Specified in its Charter)
Ohio
(State or Other Jurisdiction of Incorporation)
| |
|
|
1-11373
(Commission File Number)
|
|
31-0958666
(IRS Employer Identification
Number) |
7000 Cardinal Place, Dublin, Ohio 43017
(Address of Principal Executive Offices, Including Zip Code)
(614) 757-5000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition
The information set forth under this “Item 2.02 Results of Operations and Financial Condition”
is intended to be furnished and such information, including the exhibits furnished under this
report, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended.
On January 26, 2006, Cardinal Health, Inc. (the “Company”) issued a press release announcing
its results for the quarter and six months ended December 31, 2005. A copy of the press release is furnished
under this report as Exhibit 99.01.
Furnished under this report as Exhibit 99.02 is a discussion of the reasons why management
believes that presenting results that exclude the impact of special items and equity compensation
expense provides a useful representation of the Company’s current performance and trends.
Item 7.01 Regulation FD Disclosure
During a conference call scheduled to be held at 11:00 a.m. EST on January 26, 2006, the
Company’s Chief Financial Officer, Jeffrey W. Henderson, will discuss the Company’s results for the
quarter and six months ended December 31, 2005. The Company is furnishing Mr. Henderson’s slide presentation for
the conference call as Exhibit 99.03 to this report.
As previously disclosed, the Company continues to engage in settlement discussions with the
staff of the Securities and Exchange Commission (“SEC”) and has now reached an
agreement-in-principle on the basic terms of a potential settlement involving the Company that the
SEC staff has indicated it is prepared to recommend to the Commission. The proposed settlement is
subject to the completion of definitive documentation as well as acceptance and authorization by
the Commission and would, among other things, require the Company to pay a $35 million penalty.
The Company accordingly recorded a reserve of $10 million in the quarter ended December 31, 2005 in
addition to the $25 million reserve recorded for the fiscal year ended June 30, 2005. There can be
no assurance that the Company’s efforts to resolve the SEC’s investigation with respect to the
Company will be successful, or that the amount reserved will be sufficient, and the Company cannot
predict the timing or the final terms of any settlement.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
| |
|
|
|
|
|
|
|
|
|
99.01 |
|
|
Press release issued by the Company on January 26, 2006, and furnished under this
report. |
| |
|
|
|
|
|
|
|
|
|
99.02 |
|
|
Information released by the Company on January 26, 2006, and furnished under this
report. |
| |
|
|
|
|
|
|
|
|
|
99.03 |
|
|
Slide presentation furnished under this report. |
| |
|
|
|
|
|
|
-2-